Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial
chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing liver
transplantation. We propose that SBRT will be associated with longer time intervals between
initial treatment and the need for retreatment, compared to TACE, as a "bridge" to liver
transplantation in subjects with HCC.
Phase:
Phase 3
Details
Lead Sponsor:
Lahey Clinic
Collaborators:
Merit Medical Systems, Inc. Varian Medical Systems